P16-52. HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism by Manches, O et al.
BioMed  Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open Access Poster presentation
P16-52. HIV-activated human plasmacytoid DCs induce Tregs 
through an indoleamine 2,3-dioxygenase-dependent mechanism
O Manches*1, D Munn2, A Fallahi1, J Lifson3, L Chaperot4, J Plumas4 and 
N Bhardwaj1
Address: 1Cancer Institute, New York University Langone Medical Center, New York, USA, 2Medical College of Georgia, Augusta, GA, USA, 
3National Cancer Institute, Frederick, USA and 4INSERM U823, EFS Rhone-Alpes, La Tronche, France
* Corresponding author    
Background
Plasmacytoid dendritic cells (pDC) are crucial cells impli-
cated in anti-viral immune responses. On recognizing
HIV, they become activated, secreting high amounts of
IFNα and inflammatory cytokines, thereby potentiating
anti-viral innate and adaptive immune responses. How-
ever, the role of pDC in adaptive immunity is still
debated. Several studies have documented a role for acti-
vated pDC in the induction of CD4+ or CD8+ regulatory
T cells (Treg), both in vitro and in vivo. A direct correla-
tion between CD8+ T cell activation levels and disease
progression levels has been confirmed in many studies.
We investigated here whether HIV-stimulated pDC can
regulate the levels of immune activation by promoting the
differentiation of regulatory CD4+ T cells.
Methods
Freshly purified pDC from normal donors (New York
Blood Bank) were incubated for 7 days with purified allo-
geneic CD4+ CD25- T cells, and their suppressive activity
measured in a secondary proliferative assay. CD86/CD83
expression and cytokine secretion by monocyte-derived
DC (moDC) induced by LPS or R848 were measured in
presence or absence of CD3-activated Treg. siRNA knock-
down of NIK and IKKalpha was performed on the leuke-
mic pDC line GEN2.2 and expression of IDO was moni-
tored at the RNA and protein level.
Results
HIV-stimulated pDC were found to induce the differenti-
ation of Treg from naive CD4+ T cells, in an indoleamine
2,3 dioxygenase (IDO)-dependent way. Furthermore,
pDC-induced Treg could suppress the Toll-Like Receptor
(TLR)-mediated maturation of moDC, partially through
CTLA-4 interaction with CD80/CD86. We further show
that TLR triggering induces the activation of IDO through
the non-canonical NF-κB pathway, as evidenced by
knocking-down the expression of NIK and IKKalpha.
Conclusion
This study reveals what we believe to be a novel mecha-
nism by which pDC may regulate and potentially limit
anti-HIV immune responses, and identifies a potential tar-
get for clinical intervention.
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